YC, C., SJ, H., CY, L., CP, W., & LC, L. (2015). A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease. Medicine, 94(32), e1334. https://doi.org/10.1097/MD.0000000000001334
Chicago Style (17th ed.) CitationYC, Chen, Hwang SJ, Li CY, Wu CP, and Lin LC. "A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease." Medicine 94, no. 32 (2015): e1334. https://doi.org/10.1097/MD.0000000000001334.
MLA (9th ed.) CitationYC, Chen, et al. "A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease." Medicine, vol. 94, no. 32, 2015, p. e1334, https://doi.org/10.1097/MD.0000000000001334.